Applications are now open for the 2026 EANM Young Scientist Network Award. This new research award, supported by Advanced Accelerator Applications (a Novartis company), aims to accelerate innovative ...
Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the Fourth Transatlantic Exchange in Oncology Conference topic will be ...
EDMONTON, ALBERTA, CANADA, February 2, 2026 /EINPresswire.com/ — AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha ...
CAMBRIDGE, Mass., Sept. 9, 2025 /PRNewswire/ -- ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of Pb212 alpha radioligand therapies (ARTs), today ...
The Department of Radiology at Stanford (Calif.) Medicine is collaborating with Novartis to advance translational research in radioligand imaging. The partnership aims to accelerate early evidence ...
Belgium is moving to establish radioligand therapy as an integral pillar of cancer care. But early rollout has exposed a widening gap between breakthrough innovation and the system’s ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results